1. Ischemia reperfusion-induced metastasis is resistant to PPARγ agonist pioglitazone in a murine model of colon cancer
   Yoshihiko Tashiro et al, 2020, Scientific Reports CrossRef
2. In vivo study revealed pro-tumorigenic effect of CMTM3 in hepatocellular carcinoma involving the regulation of peroxisome proliferator-activated receptor gamma (PPARγ)
   Jiahui Wang et al, 2023, Cellular Oncology CrossRef
3. VSP-17, a New PPARγ Agonist, Suppresses the Metastasis of Triple-Negative Breast Cancer via Upregulating the Expression of E-Cadherin
   Yuhui Wang et al, 2018, Molecules CrossRef
4. Novel Targets for Treating Ischemia-Reperfusion Injury in the Liver
   Weili Yang et al, 2018, International Journal of Molecular Sciences CrossRef
5. Rosuvastatin alleviated the liver ischemia reperfusion injury by activating the expression of peroxisome proliferator-activated receptor gamma (PPARγ)
   Guiyuan Guo et al, 2021, Journal of Bioenergetics and Biomembranes CrossRef
6. PPARγ Mediates Protective Effect against Hepatic Ischemia/Reperfusion Injury via NF-κB Pathway
   Xinyu Liu et al, 2022, Journal of Investigative Surgery CrossRef
7. The forgotten type 2 diabetes mellitus medicine: rosiglitazone
   Bo Xu et al, 2022, Diabetology International CrossRef
8. Use of Steatotic Grafts in Liver Transplantation: Current Status
   Ana I. Álvarez‐Mercado et al, 2019, Liver Transplantation CrossRef
9. One Shoot, Two Birds: Alleviating Inflammation Caused by Ischemia/Reperfusion Injury to Reduce the Recurrence of Hepatocellular Carcinoma
   Hao Chen et al, 2022, Frontiers in Immunology CrossRef
10. Efficacy of traditional herbal medicine versus transcatheter arterial chemoembolization in postsurgical patients with hepatocellular carcinoma: A retrospective study
    Xizhu Xu et al, 2021, Complementary Therapies in Clinical Practice CrossRef
11. Expression of B7-H4 and hepatitis B virus X in hepatitis B virus-related hepatocellular carcinoma
    Bo Hong, 2016, World Journal of Gastroenterology CrossRef
12. Effect of sevoflurane pretreatment in relieving liver ischemia/reperfusion-induced pulmonary and hepatic injury
    Guiping Xu et al, 2019, Acta Cirurgica Brasileira CrossRef
13. New insights into molecular mechanisms of rosiglitazone in monotherapy or combination therapy against cancers
    Yi-Fan Dang et al, 2018, Chemico-Biological Interactions CrossRef